|
|
|
Qrons Inc 's vs. its Competitors Results
(List of Competitors, Financial Results 12 Months from the last period ending MRQ, in Millions of $)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
REVENUE |
NET INCOME |
NET MARGIN |
CASH FLOW |
| Qrons Inc |
3 Q 2024 |
QRON |
0.00 |
-0.39 |
- |
-0.01 |
| Amgen Inc |
3 Q 2024 |
AMGN |
32,534.00 |
4,230.00 |
13 % |
-25,730.00 |
| Gilead Sciences Inc |
3 Q 2024 |
GILD |
28,299.00 |
114.00 |
0.4 % |
-669.00 |
| Biogen Inc |
3 Q 2024 |
BIIB |
9,607.50 |
1,614.40 |
16.8 % |
-643.30 |
| Neurocrine Biosciences Inc |
3 Q 2024 |
NBIX |
2,242.80 |
385.90 |
17.21 % |
55.40 |
| Exelixis Inc |
3 Q 2024 |
EXEL |
2,081.60 |
1,066.83 |
51.25 % |
-138.51 |
| Halozyme Therapeutics Inc |
3 Q 2024 |
HALO |
947.36 |
392.47 |
41.43 % |
-119.91 |
| Coherus Biosciences inc |
3 Q 2024 |
CHRS |
304.34 |
-0.45 |
-0.15 % |
17.24 |
| Recursion Pharmaceuticals Inc |
3 Q 2024 |
RXRX |
65.18 |
-377.75 |
-579.51 % |
38.62 |
| Voyager Therapeutics Inc |
3 Q 2024 |
VYGR |
163.78 |
25.88 |
15.8 % |
48.54 |
| Sage Therapeutics Inc |
3 Q 2024 |
SAGE |
101.21 |
-430.74 |
-425.58 % |
71.36 |
| Aceragen Inc |
1 Q 2023 |
ACGN |
0.00 |
-41.05 |
- |
-25.88 |
| Anavex Life Sciences Corp |
2 Q 2024 |
AVXL |
2.58 |
-41.53 |
-1611.86 % |
-16.06 |
| Vigil Neuroscience Inc |
3 Q 2024 |
VIGL |
0.00 |
-82.60 |
- |
-11.90 |
| Zura Bio Limited |
3 Q 2024 |
ZURA |
0.00 |
5.09 |
- |
86.93 |
| Denali Therapeutics Inc |
3 Q 2024 |
DNLI |
340.81 |
-366.33 |
-107.49 % |
-57.38 |
| Neumora Therapeutics Inc |
3 Q 2024 |
NMRA |
0.00 |
-131.94 |
- |
-136.57 |
| Athira Pharma Inc |
3 Q 2024 |
ATHA |
0.00 |
-115.33 |
- |
-36.40 |
| Alvotech |
4 Q 2023 |
ALVO |
0.00 |
0.00 |
- |
0.00 |
| Ladrx Corporation |
2 Q 2024 |
LADX |
0.00 |
-2.77 |
- |
-2.79 |
| APROX. MARKET |
3 Q |
SUBTOTAL |
76,690.16 |
6,243.68 |
8.14 % |
-27,269.60 |
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
